Success Metrics

Clinical Success Rate
94.7%

Based on 18 completed trials

Completion Rate
95%(18/19)
Active Trials
7(24%)
Results Posted
28%(5 trials)
Terminated
1(3%)

Phase Distribution

Ph not_applicable
20
69%
Ph phase_1
1
3%
Ph phase_2
3
10%
Ph phase_3
5
17%

Phase Distribution

1

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
1(3.4%)
Phase 2Efficacy & side effects
3(10.3%)
Phase 3Large-scale testing
5(17.2%)
N/ANon-phased studies
20(69.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

18 of 20 finished

Non-Completion Rate

10.0%

2 ended early

Currently Active

7

trials recruiting

Total Trials

29

all time

Status Distribution
Active(7)
Completed(18)
Terminated(2)
Other(2)

Detailed Status

Completed18
Recruiting7
unknown2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
29
Active
7
Success Rate
94.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (3.4%)
Phase 23 (10.3%)
Phase 35 (17.2%)
N/A20 (69.0%)

Trials by Status

unknown27%
terminated13%
withdrawn13%
recruiting724%
completed1862%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT06117306Phase 3

MDMA-assisted Massed Prolonged Exposure for PTSD

Recruiting
NCT05758987Not Applicable

Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy

Recruiting
NCT07242586Not Applicable

PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas

Recruiting
NCT05788302Not Applicable

Mechanisms Underlying Efficacy of Prolonged Exposure

Recruiting
NCT06733376Not Applicable

Evaluating Evidenced Based Options for PTSD Treatment

Recruiting
NCT03518801Phase 2

Cannabidiol and Prolonged Exposure

Completed
NCT03485391Not Applicable

Peer Social Support During In Vivo Exposure for PTSD

Completed
NCT06285708Not Applicable

Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD

Recruiting
NCT03176953Phase 2

Topiramate and Prolonged Exposure

Completed
NCT06048172Not Applicable

Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder

Recruiting
NCT02586064Not Applicable

Comparative Effectiveness of Two Treatments for Veterans With PTSD

Completed
NCT04911010Not Applicable

Effectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic Disorder

Unknown
NCT01988935Not Applicable

Integrated PTSD and Smoking Treatment

Completed
NCT02226393Not Applicable

Evaluating Effectiveness of Dyadic Prolonged Exposure on 2-4 Years Old vs. Toddler-parent Focused Treatment

Terminated
NCT03504722Not Applicable

Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD

Completed
NCT03110302Not Applicable

In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD)

Completed
NCT02134691Not Applicable

Randomized Trial of Prolonged Exposure for the Treatment of Posttraumatic Stress Disorder (PTSD)

Completed
NCT01865123Not Applicable

A Randomized Controlled Trial of Meditation Compared to Exposure Therapy and Education Control on PTSD in Veterans

Completed
NCT03000478Not Applicable

Virtual Reality Exposure Therapy for Combat

Unknown
NCT00937235Phase 2

Treatment of Smoking Among Individuals With PTSD

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
29